Clustering Insights…exploring
Life Sciences

Clustering Insights is the podcast series that engages with key players who are active in the life sciences sector. This series will provide opinion and thought leadership from investors, developers, funders, occupiers, technical consultants and many more to give you an inside view of the sector and the role that the built environment can play to support its continued growth.

A comparison of US and UK life sciences markets – with Douglass Cuff, IQHQ

Will the UK life sciences market ever catch up to the US? In this episode we are joined by Douglass Cuff, Vice President of UK Real Estate at IQHQ. We dive into the key drivers that propelled the US market and the opportunities within the UK. He joins Chris Walters to discuss these differences, as well as the ongoing impact COVID-19 is having on the short term and long term prospects for the life sciences industry.
Listen on:

Delivering development, investment and regeneration – A sit down with Rachel Dickie, Legal & General Capital

Rachel Dickie, Director of Urban Regeneration at Legal & General Capital joins Chris Walters, Investor & Developer Life Sciences Lead at JLL to discuss the future of the life sciences industry from their perspective as a funder, investor and developer. During this podcast Rachel explains why L&G’s purpose as a company has resulted in its commitment to the sector, promoting sustainable growth that benefits society and supports economic growth across the UK. Rachel also dives into the intrinsic link between regeneration and life sciences, which she believes will grow from strength to strength in the coming years.
Listen on:

COVID-19: Impact & response – Dr Glenn Crocker, JLL­

Dr Glenn Crocker, Head of Life Sciences at JLL joins Chris Walters, Investor & Developer Life Sciences Lead to introduce Clustering Insights (our new podcast series) and discuss the impact and response to COVID-19 for investors and operators.
Listen on:


Dr Glenn Crocker – Head of Life Sciences, JLL

Dr Glenn Crocker is Head of Life Sciences for JLL. In this role he and his team advise landowners, investors and developers on where and how to buy, sell, develop, finance and attract occupiers to life science real estate. The team also supports occupiers to be in the optimum location with the right, most efficiently run property portfolio to deliver their growth strategy.

Glenn is also Chairman and Chief Investment Officer of BioCity Group, which provides facilities and develops ecosystems to support life science companies, including providing equity investment. He was the founding CEO of the business until the end of 2018. He has a DPhil in Immunology from Oxford University and qualified as a chartered accountant with EY, focusing on working with biotech companies in Palo Alto, California and Cambridge, UK, where he headed up the UK Biotech practice for EY.

He is a non-executive director of a number of life science companies and consults on business incubation, start-up creation and cluster growth. He has been directly involved in investing in life science companies through BioCity’s own or managed funds since 2006.

In 2014 Glenn received an MBE for services to the biotechnology industry.

Rachel Dickie - Director of Urban Regeneration, Legal & General Capital. 

Rachel is an Investment Director in Legal & General’s Future Cites business, leading the Urban Regeneration team. She is responsible for the sourcing, structuring and investment management of real estate projects and partnerships, including Cardiff Central Square, Newcastle Helix, Bath Quays North, L&G’s investment in Bruntwood SciTech and the recent joint venture with Oxford University. In November 2019, Rachel was appointed as the Interim CEO of the Oxford University JV.

She joined Legal & General in 2016 from Tishman Speyer, a US private equity real estate investor, developer and fund manager where she carried out several roles across real estate asset management, fund management and business development.

Rachel holds an MA in economics from the University of Cambridge.

Chris Walters – Director and Investor & Developer Lead, JLL.

Chris is an experienced Director who leads the investor and developer service line for the UK Life Sciences group at JLL. Over the past 10 years Chris has provided independent, research led advice on mixed-use development schemes with a focus on science on behalf of landowners, developers and investors in London, the UK and internationally.

He has become a recognised expert on the life sciences market with a strong understanding of the sector, emerging trends and how this translates to new build development. His expertise comprises development consultancy, appraisal and transactional advice, with a clear focus on developing delivery and funding models for clients.

Douglass Cuff is the Vice President of UK Real Estate for IQHQ, Inc.

Douglass has over 20 years’ experience working in life sciences real estate sector. Prior to IQHQ, He had various roles at BioMed Realty during his 14-year tenure.

Initially, he was responsible for overseeing the entire 1 million sq ft life science real estate portfolio in Cambridge, MA. Eventually, Douglass moved onto overseeing the completion and operation of ‘The Center for Life Science | Boston’; which is an 18 storey, first-class research facility which houses the various research groups of Children’s Hospital Boston, Beth Israel Deaconess Medical Center and the Dana Farber Cancer Institute.

Douglass then relocated to Cambridge, UK in 2012 with the acquisition of Granta Park. He expanded the initial UK portfolio by negotiating 2 pre-lets at Granta Park as well as closing a partnership with the Biotechnology and Biological Sciences Research Council at the Babraham Research Campus. Doug received a Master’s in Business Administration from Boston University and a Bachelor of Science in Biological Sciences from Fordham University in New York City.

Talk to us about
life sciences

Find out how smart location, space and facility management decisions can help fuel your scientific breakthroughs. 

Enjoying our podcast? Subscribe now